JBAFX
Price
$28.34
Change
-$0.46 (-1.60%)
Updated
Mar 10 closing price
Net Assets
5.64B
RLBCX
Price
$33.88
Change
-$0.55 (-1.60%)
Updated
Mar 10 closing price
Net Assets
237.28B
Ad is loading...

JBAFX vs RLBCX

Header iconJBAFX vs RLBCX Comparison
Open Charts JBAFX vs RLBCXBanner chart's image
JHancock Balanced R4
Price$28.34
Change-$0.46 (-1.60%)
VolumeN/A
Net Assets5.64B
American Funds American Balanced R3
Price$33.88
Change-$0.55 (-1.60%)
VolumeN/A
Net Assets237.28B
JBAFX vs RLBCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JBAFX vs. RLBCX commentary
Mar 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JBAFX is a Buy and RLBCX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 237B vs. JBAFX (5.64B). RLBCX (1.65) and JBAFX (1.60) have matching dividends . JBAFX was incepted earlier than RLBCX: JBAFX (17 years) vs RLBCX (23 years). JBAFX (0.98) is less costly to investors than RLBCX (0.89). RLBCX is a more actively managed with annual turnover of: 171.00 vs. JBAFX (67.00). JBAFX has a lower initial minimum investment than RLBCX: JBAFX (0) vs RLBCX (250). JBAFX annual gain was more profitable for investors over the last year : 5.71 vs. RLBCX (4.82). JBAFX return over 5 years is better than : 47.17 vs. RLBCX (32.76).
JBAFXRLBCXJBAFX / RLBCX
Total Expense Ratio0.870.8998%
Annual Report Gross Expense Ratio0.980.89110%
Fund Existence17 years23 years-
Gain YTD0.2090.93822%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets5.64B237B2%
Annual Yield % from dividends1.601.6597%
Returns for 1 year5.714.82118%
Returns for 3 years21.0816.52128%
Returns for 5 years47.1732.76144%
Returns for 10 years71.5050.74141%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APTO3.170.22
+7.46%
Aptose Biosciences. Inc.
CRL175.926.65
+3.93%
Charles River Laboratories International
CFB15.99N/A
N/A
CrossFirst Bankshares
XENE36.50-0.78
-2.09%
Xenon Pharmaceuticals
ALEC1.44-0.14
-8.86%
Alector